We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.00 | 4.53% | 300.00 | 298.50 | 301.50 | 304.50 | 280.50 | 280.50 | 325,249 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -6.43 | 290.22M |
TIDMOXB
RNS Number : 0652V
Oxford Biomedica PLC
25 January 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC ------ ------------------------ ---------------------------------- 2 Reason for notification Notification relates to DTR 3.1.2R ------ ------------------------ ---------------------------------- 3 Name of PDMR Martin Diggle ------ ------------------------ ---------------------------------- 4 Connected person Notification relates to following connected persons: Vulpes Life Sciences Fund ------ ------------------------ ---------------------------------- 5 Notification Notification in respect of in respect of holdings of persons in 4 above ------ ------------------------ ---------------------------------- 6 Description Oxford BioMedica PLC ordinary of shares shares of 1p each ------ ------------------------ ---------------------------------- 7 Name of registered Vulpes Life Sciences Fund shareholders - 549,732,000 shares and number of Vulpes Testudo Fund - 33,333,333 shares shares ------ ------------------------ ---------------------------------- 8 Nature of transaction Acquisition ------ ------------------------ ---------------------------------- 9 Number of shares Vulpes Life Sciences Fund acquired - 200,000 shares ------ ------------------------ ---------------------------------- 10 Percentage of Vulpes Life Sciences Fund issued class - 0.01% acquired ------ ------------------------ ---------------------------------- 11 Shares disposed N/A ------ ------------------------ ---------------------------------- 12 Percentage of N/A issued class disposed ------ ------------------------ ---------------------------------- 13/14 Price per share Vulpes Life Sciences Fund of transactions, 200,000 shares @ GBP0.042 and date , 24 Jan 2017 ------ ------------------------ ---------------------------------- 15 Total holding Vulpes Life Sciences Fund following notification - 549,932,000 shares and total percentage 17.81% holding following Vulpes Testudo Fund - 33,333,333 notification shares 1.08% ------ ------------------------ ---------------------------------- 16 Date issuer 25 Jan 2017 informed ------ ------------------------ ---------------------------------- 23 Any additional None information ------ ------------------------ ---------------------------------- 24 Contact name T. Watts, Chief Financial and telephone Officer number Oxford BioMedica +44 (0)1865 783000 ------ ------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDBBGDBGRU
(END) Dow Jones Newswires
January 25, 2017 04:02 ET (09:02 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions